PMID- 20445122 OWN - NLM STAT- MEDLINE DCOM- 20101019 LR - 20211203 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 51 IP - 10 DP - 2010 Oct TI - Altered mTOR signaling in senescent retinal pigment epithelium. PG - 5314-9 LID - 10.1167/iovs.10-5280 [doi] AB - PURPOSE: Mammalian target of rapamycin (mTOR)-mediated pathways play central roles in regulating aging. The purpose of the present study was to characterize the mTOR cascade in human retinal pigment epithelial (RPE) cells and to investigate its potential roles in controlling RPE senescence. METHODS: Expression of major components of the mTOR signaling networks was evaluated by Western blot analyses. Formations of the two signaling complexes of mTOR, mTORC1, and mTORC2 were determined by coimmunoprecipitation. The activation of mTORC1 was monitored by measuring the phosphorylation status of the downstream substrate protein S6. Senescence of the cultured human RPE cells was assessed by measuring both the senescence associated-beta-galactosidase (SA-beta-Gal) activity and the expression level of p16, a cyclin-dependent kinase inhibitor. RESULTS: Human RPE cells contained functional mTORC1 and mTORC2 signaling complexes. The assembly and activity of mTORC1 were regulated by upstream nutrient and growth factor signals. The sensitivity of mTORC1 to extracellular nutrient stimuli increased in RPE cells that had developed in vitro senescence. Suppression of the mTORC1 by rapamycin prevented the appearance of senescence markers in the RPE. CONCLUSIONS: The mTOR pathway presented age-associated changes in human RPE cells, and downregulation of mTORC1 could delay the aging process of the RPE. FAU - Chen, Yan AU - Chen Y AD - Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. yan.chen@vanderbilt.edu FAU - Wang, Jian AU - Wang J FAU - Cai, Jiyang AU - Cai J FAU - Sternberg, Paul AU - Sternberg P LA - eng GR - R01 EY007892/EY/NEI NIH HHS/United States GR - K99 EY019706/EY/NEI NIH HHS/United States GR - EY08126/EY/NEI NIH HHS/United States GR - P30 EY008126/EY/NEI NIH HHS/United States GR - EY018715/EY/NEI NIH HHS/United States GR - R21 EY018715/EY/NEI NIH HHS/United States GR - EY07892/EY/NEI NIH HHS/United States GR - K99 EY019706-01A1/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100505 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (CRTC2 protein, human) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Multiprotein Complexes) RN - 0 (Proteins) RN - 0 (Ribosomal Protein S6) RN - 0 (Transcription Factors) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.2.1.23 (beta-Galactosidase) SB - IM MH - Blotting, Western MH - Cells, Cultured MH - Cellular Senescence/*physiology MH - Cyclin-Dependent Kinase Inhibitor p16/metabolism MH - Humans MH - Immunoprecipitation MH - Intracellular Signaling Peptides and Proteins/*metabolism MH - Mechanistic Target of Rapamycin Complex 1 MH - Multiprotein Complexes MH - Phosphorylation MH - Protein Serine-Threonine Kinases/*metabolism MH - Proteins MH - Retinal Pigment Epithelium/*cytology/metabolism MH - Ribosomal Protein S6/metabolism MH - Signal Transduction/*physiology MH - TOR Serine-Threonine Kinases MH - Transcription Factors/metabolism MH - beta-Galactosidase/metabolism PMC - PMC3066610 EDAT- 2010/05/07 06:00 MHDA- 2010/10/20 06:00 PMCR- 2011/04/01 CRDT- 2010/05/07 06:00 PHST- 2010/05/07 06:00 [entrez] PHST- 2010/05/07 06:00 [pubmed] PHST- 2010/10/20 06:00 [medline] PHST- 2011/04/01 00:00 [pmc-release] AID - iovs.10-5280 [pii] AID - 10-5280 [pii] AID - 10.1167/iovs.10-5280 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5314-9. doi: 10.1167/iovs.10-5280. Epub 2010 May 5.